FebriDx®
A Rapid, Point-of-Care Test for Acute Respiratory Infections
A CLIA-waived, FDA-cleared fingerstick blood test that helps clinicians determine if a patient's acute respiratory infection is more likely bacterial or non-bacterial (viral).
Fast, Simple, Accurate
Designed for frontline clinical settings where speed and simplicity matter most.
Results in ~10 Minutes
Fast, actionable results for point-of-care settings
CLIA Waived
Cleared for use in physician offices, urgent care, and clinics
No Analyzer Required
Simple fingerstick test — no special equipment needed
Patented Technology
INDICAID® FebriDx® — proven diagnostic accuracy
Why It Matters
Helps guide the right treatment decision by distinguishing bacterial vs. non-bacterial (viral) respiratory infections.
Supports antibiotic stewardship by helping reduce unnecessary antibiotic prescribing.
Fast, simple fingerstick test designed for urgent care, primary care, walk-in clinics, and other frontline medical settings.
Reimbursable by Insurance
- PLA Code0442U-QW
- Medicare Reimbursement$41.38
- Commercial CoverageAlso covered by many commercial insurance plans (rates vary by payer).
Interested in Wholesale Pricing for FebriDx®?
Home Health Brands is an authorized distributor. Contact our team for volume pricing and availability.